List of works - Yannick Vermeiren

Age- and disease-specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease

scientific article published on 25 August 2019

Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models

scientific article published on 14 June 2017

Antigen-specific age-related memory CD8 T cells induce and track Alzheimer's-like neurodegeneration

scientific article published on 16 July 2024

Antigen-specific age-related memory CD8 T cells induce and track Alzheimer's-like neurodegeneration

scientific article published on 22 January 2024

Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia.

scientific article

Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults.

scientific article published on 30 April 2012

Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease?

scientific article published on 13 August 2015

Brain Kynurenine Pathway Metabolite Levels May Reflect Extent of Neuroinflammation in ALS, FTD and Early Onset AD

scientific article published on 19 April 2023

Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.

scientific article published on 15 June 2016

Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease

scientific article published in January 2014

Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

scientific article published on 6 February 2018

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease

scientific article published on 20 February 2021

Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.

scientific article published in January 2018

Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum ⬇️

scientific article published on 04 March 2020

Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease.

scientific article published on 23 November 2017

Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease

scientific article

Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?

scientific article

Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression

scientific article published on 05 October 2016

Novel and sensitive reversed-phase high-pressure liquid chromatography method with electrochemical detection for the simultaneous and fast determination of eight biogenic amines and metabolites in human brain tissue.

scientific article

Pre-analytical stability of novel cerebrospinal fluid biomarkers

scientific article published on 23 July 2019

Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.

scientific article published on 17 December 2012

Rapid Reconfiguration of the Functional Connectome after Chemogenetic Locus Coeruleus Activation

scientific article published on 18 June 2019

Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient

scientific article published on 26 April 2019

Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes.

scientific article published on 20 March 2018

Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with Down syndrome.

scientific article

Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome

scientific article published in January 2015

Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease

scientific article published on 20 May 2011

Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story

scientific article published on 26 November 2016

The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome

scientific article published on 16 April 2018

The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease

scientific article

[The behavioral and psychological symptoms of dementia in down syndrome (BPSD-DS) scale: comprehensive assessment of psychopathology in down syndrome]

scientific article published on 20 September 2018

List of works by Yannick Vermeiren

Age- and disease-specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease

Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models

Antigen-specific age-related memory CD8 T cells induce and track Alzheimer's-like neurodegeneration

Antigen-specific age-related memory CD8 T cells induce and track Alzheimer's-like neurodegeneration

Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia.

Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults.

Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease?

Brain Kynurenine Pathway Metabolite Levels May Reflect Extent of Neuroinflammation in ALS, FTD and Early Onset AD

Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.

Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease

Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease

Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.

Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum ⬇️

Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease.

Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease

Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?

Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression

Novel and sensitive reversed-phase high-pressure liquid chromatography method with electrochemical detection for the simultaneous and fast determination of eight biogenic amines and metabolites in human brain tissue.

Pre-analytical stability of novel cerebrospinal fluid biomarkers

Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.

Rapid Reconfiguration of the Functional Connectome after Chemogenetic Locus Coeruleus Activation

Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient

Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes.

Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with Down syndrome.

Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome

Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease

Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story

The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome

The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease

[The behavioral and psychological symptoms of dementia in down syndrome (BPSD-DS) scale: comprehensive assessment of psychopathology in down syndrome]